Výsledky vyhľadávania - "Anemia, Sickle Cell complications"

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Zdroj: Blood Adv
    Brandsen, R P, Diederen, R M H, Bakhlakh, S, Nur, E, Schlingemann, R O & Biemond, B J 2023, 'Natural history and rate of progression of retinopathy in adult patients with sickle cell disease : an 11-year follow-up study', Blood, vol. 7, no. 13, pp. 3080-3086. https://doi.org/10.1182/bloodadvances.2022009147
    Blood advances, vol. 7, no. 13, pp. 3080-3086

    Popis súboru: application/pdf

  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Prispievatelia: Megan M Miller Deanna D Rumble Adam T Hirsh a ďalší

    Zdroj: Miller, M M, Rumble, D D, Hirsh, A T, Vervoort, T, Crosby, L E, Madan-Swain, A, Lebensburger, J, Hood, A M & Trost, Z 2021, ' Pain-Related Injustice Appraisals in Youth with Sickle Cell Disease : A Preliminary Investigation ', Pain Medicine, vol. 22, no. 10, pp. 2207-2217 . https://doi.org/10.1093/pm/pnab001

    Popis súboru: application/pdf

  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Zdroj: European Journal of Haematology. 102:123-130

    Predmety: Male, thalassemia, drug safety, creatinine blood level, Survival, Turkey, preschool child, Cohort Studies, iron, 0302 clinical medicine, Iron-Overloaded Patients, Disease, Child, Pediatric, child, iron chelation, chelation therapy, adult, creatinine, Anemia, kidney tubule disorder, clinical trial, biological marker, cohort analysis, Sickle Cell, 3. Good health, female, Treatment Outcome, priority journal, monotherapy, Child, Preschool, Pediatric-Patients, Thalassemia, Female, liver enzyme, Safety, Hemoglobinopathy, deferasirox, Iron Overload, erythrocyte transfusion, side effect, Efficacy, Adolescent, Iron, complication, Chelation-Therapy, Anemia, Sickle Cell, protein urine level, blood transfusion, Deferoxamine, Iron Chelating Agents, Anemia, Sickle Cell/*complications/therapy, Biomarkers, Blood Transfusion, Deferasirox/administration & dosage/adverse effects/*therapeutic use, Ferritins/blood/metabolism, Humans, Iron/blood/metabolism, Iron Chelating Agents/administration & dosage/adverse effects/*therapeutic use, Iron Overload/*drug therapy/*etiology/metabolism, Thalassemia/*complications/therapy, Article, enzyme blood level, 03 medical and health sciences, sickle cell anemia, male, blood, turkey (bird), Escalator, follow up, hemoglobinopathy, human, Medically Treated Patients, drug dose reduction, iron overload, Preschool, transfusion, Transfusion, ferritin, abdominal pain, iron chelating agent, school child, major clinical study, Iron Chelation, drug efficacy, ferritin blood level, Deferasirox, multicenter study, pediatric, adolescent, Ferritins, treatment outcome, observational study, proteinuria, metabolism

    Popis súboru: application/pdf

  17. 17
  18. 18

    Zdroj: Heeney, M M, Hoppe, C C, Abboud, M R, Inusa, B, Kanter, J, Ogutu, B, Brown, P B, Heath, L E, Jakubowski, J A, Zhou, C, Zamoryakhin, D, Agbenyega, T, Colombatti, R, Hassab, H M, Nduba, V N, Oyieko, J N, Robitaille, N & Segbefia, C I & Rees, D C 2016, ' A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events ', New England Journal of Medicine, vol. 374, no. 7, pp. 625-635 . https://doi.org/10.1056/NEJMoa1512021

    Popis súboru: application/pdf

  19. 19
  20. 20

    Zdroj: Rev Bras Hematol Hemoter
    Revista Brasileira de Hematologia e Hemoterapia, Vol 34, Iss 2, Pp 156-164 (2012)
    Revista Brasileira de Hematologia e Hemoterapia v.34 n.2 2012
    Revista brasileira de hematologia e hemoterapia
    Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
    instacron:ABHHTC
    Revista Brasileira de Hematologia e Hemoterapia, Volume: 34, Issue: 2, Pages: 156-164, Published: 2012

    Popis súboru: text/html